معرفی
Peter Verrijzer is a Full Professor in the Department of Biochemistry at Erasmus University Medical Center, Rotterdam. His research spans epigenetics, chromatin biology, and cancer mechanisms with significant contributions to understanding Polycomb group proteins and nucleosome remodeling.
His primary research interests focus on epigenetic regulation in cancer development, particularly:
- PRC1-mediated transcriptional silencing and nucleosome dynamics
- Ubiquitin signaling in neuronal differentiation and cancer
- Metabolism-epigenetics crosstalk through moonlighting enzymes
- Oral cancer pathogenesis involving epithelial-mesenchymal transition
Recent publications reveal strong trends in chromatin remodeling complexes and their role in disease. His work connects Polycomb biology with cancer progression, showing how PRC1 variants regulate developmental genes and how metabolic enzymes moonlight as epigenetic regulators. Key publications examine USP7's role in neurodevelopment and DOC1 tumor suppressor mechanisms in oral cancer.
Verrijzer actively supervises graduate research with 17 supervised works documented, though specific student names aren't listed. His laboratory investigates chromatin architecture using biochemical and genomic approaches, focusing on how epigenetic dysregulation drives oncogenesis. Current projects include analyzing non-canonical PRC1 complexes and their evolutionary origins.
